Chemical Component Summary

Name5-BROMO-2'-DEOXY URIDINE
Identifiers5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
FormulaC9 H11 Br N2 O5
Molecular Weight307.098
TypeDNA LINKING
Isomeric SMILESC1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O
InChIInChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
InChIKeyWOVKYSAHUYNSMH-RRKCRQDMSA-N

Chemical Details

Formal Charge0
Atom Count28
Chiral Atom Count3
Bond Count29
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB12028 
NameBroxuridine
Groups investigational
DescriptionBroxuridine has been used in trials studying the treatment of Leukemia, Stage I Prostate Cancer, Stage IIB Prostate Cancer, and Stage IIA Prostate Cancer.
Synonyms
  • Broxuridina
  • Bromodeoxyuridine
  • Broxuridine
Categories
  • Anti-Infective Agents
  • Antimetabolites
  • Antineoplastic Agents
  • Deoxyribonucleosides
  • Deoxyuridine
CAS number59-14-3

Related Resource References

Resource NameReference
PubChem 6035
ChEMBL CHEMBL222280
ChEBI CHEBI:472552
CCDC/CSD BROXUR11
COD 2215590